Skip to main content
SpringerLink
Log in

Charcot-Marie-Tooth Disease and Related Peripheral Neuropathies

  • Chapter
Principles of Molecular Medicine

  • 183 Accesses

Abstract

Molecular genetic analysis of the demyelinating neuropathies Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies has uncovered a novel mutational mechanism whereby a reciprocal recombination involving a misaligned flanking repeat sequence results in both the Charcot-Marie-Tooth disease type-1A duplication and hereditary neuropathy with liability to pressure palsies deletion. These studies have illuminated the role that gene dosage may play in causing a disease phenotype, which has important implications for therapeutic strategies, and which may underlie the basis of the extreme clinical variability. The identification of these rearrangement mutations (duplication and deletion) has resulted in the availability of molecular procedures for establishing or excluding a secure diagnosis, enabling presymptomatic and prenatal diagnosis, and providing prognostic information.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 269.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 349.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

Selected References

  • Adlkofer K, Martini R, Aguzzi A, Zielasek J, Toyka KV, Suter U. Hyper-myelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat Genet 1995;11:274–280.

    Article  PubMed  CAS  Google Scholar 

  • Antonellis A, Ellsworth RE, Sambuughin N, et al. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease Type 2D and distal spinal muscular atrophy Type V. Am J Hum Genet 2003;72:1293–1299.

    Article  PubMed  CAS  Google Scholar 

  • Berger P, Bonneick S, Willi S, Wymann M, Suter U. Loss of phosphatase activity in myotubularin-related protein 2 is associated with Charcot-Marie-Tooth disease type 4B1. Hum Mol Genet 2002;11: 1569–1579.

    Article  PubMed  CAS  Google Scholar 

  • Berger P, Young P, Suter U. Molecular cell biology of Charcot-Marie-Tooth disease. Neurogenetics 2002;4:1–15.

    Article  PubMed  CAS  Google Scholar 

  • Bergoffen J, Scherer SS, Wang S, et al. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 1993;262:2039–2042.

    Article  PubMed  CAS  Google Scholar 

  • Boerkoel CF, Lupski JR. Hereditary motor and sensory neuropathies. In: Rimoin DL, Conner JM, Pyeritz RE, Korf BR, eds. Principles and Practice of Medical Genetics, 4th ed. London: Harcourt, 2002; pp. 3303–3320.

    Google Scholar 

  • Boerkoel CF, Takashima H, Garcia CA, et al. Charcot-Marie-Tooth disease and related neuropathies: Mutation distribution and genotype-phenotype correlation. Ann Neurol 2002;51:190–201.

    Article  PubMed  CAS  Google Scholar 

  • Boerkoel CF, Takashima H, Lupski JR. The genetic convergence of Charcot-Marie-Tooth disease types 1 and 2 and the role of genetics in sporadic neuropathy. Curr Neurol Neurosci Rep 2002;2:70–77.

    Article  PubMed  Google Scholar 

  • Boerkoel CF, Takashima H, Nakagava M, et al. CMT4A: Identification of a hispanic GDAP1 founder mutation. Ann Neurol 2003;53:400–405.

    Article  PubMed  CAS  Google Scholar 

  • Boerkoel CF, Takashima H, Stankiewicz P, et al. Periaxin mutations cause recessive Dejerine-Sottas neuropathy. Am J Hum Genet 2001;68: 325–333.

    Article  PubMed  CAS  Google Scholar 

  • Caldecott K. DNA single-strand break repair and spinocerebellar ataxia. Cell 2003;112:7–10.

    Article  PubMed  CAS  Google Scholar 

  • Chance PF, Alderson MK, Leppig KA, et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 1993;72:143–151.

    Article  PubMed  CAS  Google Scholar 

  • De Sandre-Giovannoli A, Chaouch M, Kozlov S, et al. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause auto-somal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet 2002;70:726–736.

    Article  PubMed  Google Scholar 

  • Dyck PJ, Oviatt KF, Lambert EH. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol 1981;10: 222–226.

    Article  PubMed  CAS  Google Scholar 

  • Garcia CA. Familial neuropathies. In: Johnson RT, Griffins JW, eds. Current Therapy in Neurologic Disease, 5th ed. St. Louis: Mosby-Year Book, 1997; pp. 386–388.

    Google Scholar 

  • Graf WD, Chance PF, Lensch MW, Eng LJ, Lipe HP, Bird TD. Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A. Cancer 1996;77:1356–1362.

    Article  PubMed  CAS  Google Scholar 

  • Hoogendijk JE, Hensels GW, Gabreels-Festen AAWM, et al. De-novo mutation in hereditary motor and sensory neuropathy type 1. Lancet 1992;339:1081, 1082.

    Article  PubMed  Google Scholar 

  • Inoue K, Dewar K, Katsanis N, et al. The 1.4 Mb CMT1A duplication/ HNPP deletion genomic region reveals unique genome architectural features and provides insights into the recent evolution of new genes. Genome Res 2001;11:1018–1033.

    Article  PubMed  CAS  Google Scholar 

  • Inoue K, Shilo K, Boerkoel C, et al. Congenital hypomyelinating neuropathy and Waardenburg syndrome: Phenotypes linked by SOX10 gene mutation. Ann Neurol 2001;52:836–842.

    Article  CAS  Google Scholar 

  • Inoue K, Tanabe Y, Lupski JR. Myelin deficiencies in both the central and the peripheral nervous systems associated with a SOX10 mutation. Ann Neurol 1999;46:313–318.

    Article  PubMed  CAS  Google Scholar 

  • Jordanova A, De Jonge P, Boerkoel CF, et al. Mutations in the neurofila-ment light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease. Brain 2003;126:590–597.

    Article  PubMed  CAS  Google Scholar 

  • Jordanova A, Irobi J, Thomas FP, et al. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neutopathy. Nat Genet 2006;38:197–202.

    Article  PubMed  CAS  Google Scholar 

  • Lupski JR, Garcia CA. Charcot-Marie-Tooth peripheral neuropathies and related disorders. In: Scriver CR, Beaudet AL, Sly WS, et al., eds. The Metabolic and Molecular Bases of Inherited Disorders, 8th ed. New York: McGraw-Hill, 2001; pp. 5759–5788.

    Google Scholar 

  • Lupski JR, Chance PF, Garcia CA. Inherited primary peripheral neuropathies: Molecular genetics and clinical implications of CMT1A and HNPP. JAMA 1993;270:2326–2330.

    Article  PubMed  CAS  Google Scholar 

  • Lupski JR, Montes de Oca-Luna R, Slaugenhaupt S, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991; 66:219–232.

    Article  PubMed  CAS  Google Scholar 

  • Lupski JR, Wise CA, Kuwano A, et al. Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A. Nat Genet 1992;1:29–33.

    Article  PubMed  CAS  Google Scholar 

  • Nelis E, Van Broekhoven C, De Jonghe P, et al. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies; a European collaborative study. Eur J Hum Genet 1996;4:25–33.

    PubMed  CAS  Google Scholar 

  • Nicholson GA, Valentijn LJ, Cherryson AK, et al. A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies. Nat Genet 1994;6:263–266.

    Article  PubMed  CAS  Google Scholar 

  • Niemann A, Ruegg M, La Padula V, Schenone A, Suter U. Ganglioside-induced differentiation associated protein 1 is a regulator of the mito-chondrial network: new implications for Charcot-Marie-Tooth disease. J Cell Biol 2005;170:1067–1078.

    Article  PubMed  CAS  Google Scholar 

  • Ouvrier RA, Nicholson GA. Advances in the genetics of hereditary hyper-trophic neuropathy in childhood. Brain Dev 1995; 17:31–38.

    Article  PubMed  Google Scholar 

  • Palau F, Lofgren A, De Jonghe P, et al. Origin of the de novo duplication in Charcot-Marie-Tooth disease type 1A: Unequal nonsister chro-matid exchange during spermatogenesis. Hum Mol Genet 1993;2: 2031–2035.

    Article  PubMed  CAS  Google Scholar 

  • Passage E, Norreel JC, Noack-Fraissignes P, Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat Med 2004;10:396–401.

    Article  PubMed  CAS  Google Scholar 

  • Pentao L, Wise CA, Chinault AC, Patel PI, Lupski JR. Charcot-Marie-Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit. Nat Genet 1992;2:292–300.

    Article  PubMed  CAS  Google Scholar 

  • Perea J, Robertson A, Tolmachova T, et al. Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A. Hum Mol Genet 2001;10:1007–1018.

    Article  PubMed  CAS  Google Scholar 

  • Planté-Bordeneuve V, Guiochon-Mantel A, Lacroix C, Lapresle J, Said G. The Roussy-Lévy family: From the original description to the gene. Ann Neurol 1999;46:770–773.

    Article  PubMed  Google Scholar 

  • Puls I, Jonnakuty C, LaMonte BH, et al. Mutant dynactin in motor neuron disease. Nat Genet 2003;33:455, 456.

    Article  PubMed  CAS  Google Scholar 

  • Raeymaekers P, Timmerman V, Nelis V, et al. Duplication in chromosome 17p1 1.2 in Charcot-Marie-Tooth neuropathy type 1a (CTM1a). Neuromuscul Disord 1991;2:93–97.

    Article  Google Scholar 

  • Roa BB, Garcia CA, Suter U, et al. Charcot-Marie-Tooth disease type 1A: Association with a spontaneous point mutation in the PMP22 gene. N Engl J Med 1993;329:96–101.

    Article  PubMed  CAS  Google Scholar 

  • Ryan MC, Shooter EM, Notterpek L. Aggresome formation in neuropathy models based on peripheral myelin protein 22 mutations. Neurobiol Dis 2002;10:109–118.

    Article  PubMed  CAS  Google Scholar 

  • Saifi GM, Szigeti K, Snipes GJ, Garcia CA, Lupski JR. Molecular mechanisms, diagnosis, and rational approaches to management of and therapy for Charoct-Marie-Tooth disease and related peripheral neuropathies. J Investig Med 2003;51:261–283.

    Article  PubMed  CAS  Google Scholar 

  • Scherer SS, Arroyo EJ. Recent progress on the molecular organization of myelinated axons. J Peripher Nerv Syst 2002;7:1–12.

    Article  PubMed  CAS  Google Scholar 

  • Senderek J, Bergmann C, Weber S, et al. Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. Hum Mol Genet 2003;12:349–356.

    Article  PubMed  CAS  Google Scholar 

  • Sereda M, Griffiths I, Puhlohofer A, et al. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 1996;16:1049–1060.

    Article  PubMed  CAS  Google Scholar 

  • Sereda MW, Meyer zu Hörste G, Suter U, Uzma N, Nave KA. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat Med 2003;9:1533–1537.

    Article  PubMed  CAS  Google Scholar 

  • Street VA, Bennett CL, Goldy JD, et al. Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C. Neurology 2003;60:22–26.

    Article  PubMed  CAS  Google Scholar 

  • Suter U, Moskow JJ, Welcher AA, et al. A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse. Proc Natl Acad Sci USA 1992;89:4382–4386.

    Article  PubMed  CAS  Google Scholar 

  • Suter U, Snipes GJ, Schoener-Scott R, et al. Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters. J Biol Chem 1994;269: 25,795–25,808.

    PubMed  CAS  Google Scholar 

  • Suter U, Welcher AA, Ozcelik T, et al. Trembler mouse carries a point mutation in a myelin gene. Nature 1992;19:241–244.

    Article  Google Scholar 

  • Szigeti K, Saifi GM, Armstrong D, Belmont JW, Miller G, Lupski JR. Disturbance of muscle fiber type differentiation in congenital hypomyelinating neuropathy caused by a novel myelin protein zero mutation. Ann Neurol 2003;54:398–402.

    Article  PubMed  CAS  Google Scholar 

  • Takashima H, Boerkoel CF, DeJonghe P, et al. Periaxin mutations cause a broad spectrum of demyelinating neuropathies. Ann Neurol 2002; 51:709–715.

    Article  PubMed  CAS  Google Scholar 

  • Takashima H, Boerkoel CF, John J, et al. Mutation of Tdp1, a topoiso-merase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy. Nat Genet 2002;32:267–272.

    Article  PubMed  CAS  Google Scholar 

  • Takashima H, Boerkoel CF, Lupski JR. Screening for mutations in a genetically heterogeneous disorder: DHPLC versus DNA sequence for mutation detection in multiple genes causing Charcot-Marie-Tooth neuropathy. Genet Med 2001;5:335–342.

    Article  Google Scholar 

  • Tyson J, Malcolm S, Thomas PK, Harding AE. Deletions of chromosome 17p11.2 in multifocal neuropathies. Ann Neurol 1996;39: 180–186.

    Article  PubMed  CAS  Google Scholar 

  • Valentijn LJ, Baas F, Wolterman RA, et al. Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type a. Nat Genet 1992;2:288–291.

    Article  PubMed  CAS  Google Scholar 

  • Verhoeven K, De Jonghe P, Coen K, et al. Mutations in the small GTP-aselate endosomal protein RAB7 cause Charcot-Marie-Tooth Type 2B neuropathy. Am J Hum Genet 2003;72:722–727.

    Article  PubMed  CAS  Google Scholar 

  • Warner LE, Mancias P, Butler IJ, et al. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet 1998;18:382–384.

    Article  PubMed  CAS  Google Scholar 

  • Wise CA, Garcia CA, Davis S, et al. Molecular analyses of unrelated Charcot-Marie-Tooth disease patients reveal a high frequency of the CMT1A duplication. Am J Hum Genet 1993;53:853–863.

    PubMed  CAS  Google Scholar 

  • Yoshikawa H, Nishimura T, Nakatsuji Y, et al. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A. Ann Neurol 1994;35:445–450.

    Article  PubMed  CAS  Google Scholar 

  • Zuchner S, Mersiyanova IV, Muglia M, et al. Mutations in the mitochon-drial GTPase mitofusion 2 cause Charcot-Marie-Tooth neutopathy type 2A. Nat Genet 2004;36:449–451.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular and Human Genetics, Department of Pediatrics, Baylor College of Medicine, Texas Children’s Hospital, Houston, TX

    James R. Lupski

Authors
  1. James R. Lupski
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medicine, Division of Cardiology Carolina Cardiovascular Biology Center, University of North Carolina School of Medicine, Chapel Hill, NC

    Marschall S. Runge MD, PhD  & Cam Patterson MD  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc.

About this chapter

Cite this chapter

Lupski, J.R. (2006). Charcot-Marie-Tooth Disease and Related Peripheral Neuropathies. In: Runge, M.S., Patterson, C. (eds) Principles of Molecular Medicine. Humana Press. https://doi.org/10.1007/978-1-59259-963-9_114

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-963-9_114

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-202-5

  • Online ISBN: 978-1-59259-963-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation